Algenpantucel-l clinical trials
How each study uses algenpantucel-l is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2005 (1)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses algenpantucel-l is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Vaccine Treatment for Surgically Resected Pancreatic CancerCompletedPhase 1/2NewLink Genetics CorporationNCT00255827Written as HyperAcute-Pancreatic Cancer VaccineHow we know
- Immunotherapy Study for Surgically Resected Pancreatic CancerCompletedPhase 3NewLink Genetics CorporationNCT01072981Written as HyperAcute-Pancreas ImmunotherapyHow we know
- Vaccine Study for Surgically Resected Pancreatic CancerCompletedPhase 2NewLink Genetics CorporationNCT00569387Written as HyperAcute(R)-Pancreatic Cancer VaccineHow we know
- Low Dose Vaccine Study for Surgically Resected Pancreatic CancerTerminatedPhase 2NewLink Genetics CorporationNCT00614601Written as HyperAcute(R)-Pancreatic Cancer VaccineHow we know
Codes
What other systems call algenpantucel-l · ClinicalTrials.gg INT016828
- UNII (FDA) I6HAD3HP89ALGENPANTUCEL-LOne source FDA
- NCI Thesaurus C61082Algenpantucel-LOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | I6HAD3HP89 | ALGENPANTUCEL-L | One source FDA |
| NCI Thesaurus | C61082 | Algenpantucel-L | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.